Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Clinical trial NCT00004067 · COMPLETED
Trial details
- NCT number
- NCT00004067
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Primary completion
- 2005-03-01
- Enrollment
- 2130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.